Fosun: Initiate at OP; Discipline Fuels Resilience

Fosun: Initiate at OP; Discipline Fuels Resilience

Pius Xue, CFA - Senior Analyst, CreditSights
Zoey Zhou Qianyun, CFA - Analyst, East Asia Corporates, CreditSights

27 November 2025

Download the Full Report to Gain:

Insights into Fosun International credit analysis, including:

  • Diversified Investment Portfolio Strategy: Discover how Fosun International’s credit profile benefits from a well-balanced portfolio across health, happiness, wealth, and intelligent manufacturing segments, with 53% of revenue generated overseas and low single-name concentration risk.
  • Holdco-Level Liquidity Assessment: Learn how our Fosun International credit analysis evaluates the holding company’s capital structure, including RMB 89 bn in debt as of 1H25, with 74% from bank loans and improving access to both onshore and offshore capital markets.
  • Core Asset Performance Review: Explore detailed financial metrics for Fosun’s key investments including Fosun Pharma (15% of portfolio value), BCP (12%), Fidelidade (10%), and Yuyuan (8%), with comprehensive analysis of their operational resilience and credit metrics.
  • Asset Monetization Capability: See how Fosun has realized approximately RMB 71 bn through strategic disposals since FY22, demonstrating strong ability and willingness to optimize portfolio composition and manage leverage at the holdco level.
  • Loan-to-Value Coverage Analysis: Gauge Fosun’s moderate leverage position with a 40.4% LTV ratio as of 1H25, supported by our comprehensive portfolio valuation methodology that accounts for both listed (43%) and unlisted (57%) holdings across multiple geographies.

Executive Summary

  • We expect Fosun International’s credit metrics to remain supported by the stable to improving performance of its core investments in FY26, alongside gradual deleveraging through non-core asset disposals in the medium term; on a relative value basis, its $ bonds offer value compared to China BB-rated peers and broader Asia HY investment holding names, and can see potential for spreads to tighten by 30 bp.

  • Fosun is a Hong Kong incorporated investment holding company listed on the Hong Kong Stock Exchange since 2007; it is 73% held by Fosun Holdings, which is in turn controlled by Guo Guangchang, co-founder and chairman, and Wang Qunbin, co-founder and co-chairman.

  • Fosun has four business segments – health, happiness, wealth (insurance and asset management) and intelligent manufacturing; it operates as an investment holding company, making strategic decisions on acquisitions, divestments and financing over its portfolio assets.

  • We (1) valued Fosun’s portfolio assets as part of the loan-to-value analysis, (2) analyzed its key assets, including Fosun Pharma, Yuyuan, Fosun Tourism Group, Fidelidade, Banco Comercial Português, Peak Reinsurance, and Hainan Mining, and (3) reviewed its holding company-level capital structure and liquidity.

  • Fosun’s credit profile is underpinned by diversified investment portfolio across sectors and geographies, improving access to bank and capital markets, as well as the strong ability and willingness to monetize assets; these strengths mitigate concerns over its volatile income stream and heavy reliance on short-term financing, volatility in portfolio value on mark-to-market of listed assets, lack of transparency around unlisted portfolio assets, underperformance of certain subsidiaries/investments, as well as key man risk.

Fill out the below form to view the full article:

Please note that we can only respond to valid business email addresses and the interview is already available to clients.

Stay in the loop with the latest credit insights direct to your inbox